Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

ClinicalTrials.gov ID: NCT05701995

Public ClinicalTrials.gov record NCT05701995. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 11:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effect of deucravacitinib on quality of life (QoL) in participants with plaque psoriasis in a community setting.

Study identification

NCT ID
NCT05701995
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
180 participants

Conditions and interventions

Conditions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 30, 2023
Primary completion
Aug 22, 2024
Completion
May 28, 2025
Last update posted
Jun 2, 2026

2023 – 2025

United States locations

U.S. sites
35
U.S. states
18
U.S. cities
34
Facility City State ZIP Site status
Local Institution - 0006 Phoenix Arizona 85006
Local Institution - 0034 Scottsdale Arizona 85260
Local Institution - 0015 North Little Rock Arkansas 72117
Local Institution - 0004 Bakersfield California 93309
Local Institution - 0009 Sacramento California 95815
Local Institution - 0022 San Diego California 92103
Local Institution - 0030 Centennial Colorado 80111
Local Institution - 0024 Washington D.C. District of Columbia 20016
Local Institution - 0027 Brandon Florida 33511
Local Institution - 0016 Coral Gables Florida 33134
Riverchase Dermatology Pembroke Pines Florida 33028
Local Institution - 0037 Atlanta Georgia 30331
Local Institution - 0020 Snellville Georgia 30078
Local Institution - 0007 Rolling Meadows Illinois 60008
Local Institution - 0025 Skokie Illinois 60077
Local Institution - 0036 Springfield Illinois 62703
Local Institution - 0003 Baton Rouge Louisiana 70809
Local Institution - 0018 Rockville Maryland 20850
Local Institution - 0010 Auburn Hills Michigan 48326
Local Institution - 0002 Waterford Michigan 48328
Local Institution - 0017 Las Vegas Nevada 89148
Local Institution - 0035 Reno Nevada 89509
Local Institution - 0032 New York New York 10011
Local Institution - 0013 New York New York 10128
Local Institution - 0001 Rochester New York 14623
Local Institution - 0005 Bexley Ohio 43209
Local Institution - 0012 Mayfield Heights Ohio 44124
Local Institution - 0019 Charleston South Carolina 29407
Local Institution - 0029 Cypress Texas 77433
Local Institution - 0028 Frisco Texas 75034
Local Institution - 0008 South Jordan Utah 84095
Local Institution - 0033 Springville Utah 84663
Local Institution - 0021 Bellevue Washington 98004
Local Institution - 0031 Mill Creek Washington 98012
Local Institution - 0014 Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05701995, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 2, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05701995 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →